Michael J. Baughman - 06 Nov 2023 Form 4 Insider Report for EMERSON ELECTRIC CO (EMR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Nov 2023, 18:11:18 UTC
Prior SEC filing
02 Nov 2022
Next SEC filing
06 Nov 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John Sperino, Attorney-in-Fact for Michael J. Baughman

Key filing fact

Michael J. Baughman filed Form 4 for EMERSON ELECTRIC CO (EMR) on 08 Nov 2023.

Key facts

  • This page summarizes Michael J. Baughman's Form 4 filing for EMERSON ELECTRIC CO (EMR).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Nov 2023, 18:11.

Change

  • Previous filing in this sequence was filed on 02 Nov 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EMR transaction

Common Stock

Award

Transaction value
Shares
+10,276
Change %
+18%
Price
Shares after
68,650
Date
06 Nov 2023
Ownership
Direct
Footnotes
F1, F2, F3
EMR transaction

Common Stock

Award

Transaction value
Shares
+13,641
Change %
+20%
Price
Shares after
82,291
Date
06 Nov 2023
Ownership
Direct
Footnotes
F4, F5
EMR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
543
Date
06 Nov 2023
Ownership
401(k) excess plan
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Acquisition of 10,276 shares pursuant to Rule 16b-3 upon payout of 18,684 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2023. Of these 18,684 units, 10,276 units were paid in shares of Issuer stock, with the remaining 8,408 units paid in cash to cover the reporting person's tax obligations.

Footnote F2

Price is not applicable to the acquisitions described in Note 1.

Footnote F3

Includes 569 shares acquired under Dividend Reinvestment Plans ("DRIPs").

Footnote F4

Grant to Reporting Person of 13,641 restricted stock units under shareholder approved benefit plan pursuant to Rule 16b-3(d).

Footnote F5

Price is not applicable to acquisitions resulting from grants of restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .